HEMO — Hemogenyx Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Hemogenyx Pharmaceuticals, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1.81	6.84	2.53	1.25	0.159
Net Total Accounts Receivable
Net Total Receivables	0.056	0.008	0.01	0.005	0.008
Prepaid Expenses
Total Current Assets	1.92	7.14	2.59	2.17	0.839
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.269	0.797	3.92	3.31	2.73
Net Intangible Assets
Other Long Term Assets
Total Assets	2.66	8.52	7.09	6.11	4.21
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	1.78	0.353	0.748	0.652	1.16
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	1.77	0.329	3.82	3.29	3.31
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.891	8.19	3.28	2.82	0.898
Total Liabilities & Shareholders' Equity	2.66	8.52	7.09	6.11	4.21
Total Common Shares Outstanding